You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I adenoid cystic carcinoma of the oral cavity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
  • San Francisco, California
    University of California, San Francisco
Oct 18, 2023

Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Melbourne (TetMYB Vaccine, BGB-A317)

Active, not recruiting
  • Colorectal Cancer
  • Adenoid Cystic Carcinoma
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 16, 2022

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,

Terminated
Has Results
  • Stage I Oral Cavity Squamous Cell Carcinoma
  • Stage II Oral Cavity Squamous Cell Carcinoma
  • Buffalo, New York
  • +1 more
May 6, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma

Completed
Has Results
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • +11 more
  • Duarte, California
  • +11 more
Jul 14, 2020

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,

Active, not recruiting
  • Melanoma (Skin)
  • +3 more
  • CV8102
  • CV8102 + anti-PD-1 therapy
  • Graz, Austria
  • +21 more
Nov 3, 2021

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma Trial in Canada,

Recruiting
  • Buccal Mucosa Squamous Cell Carcinoma
  • +11 more
  • Computed Tomography (CT)
  • +5 more
  • Tucson, Arizona
  • +71 more
Jan 11, 2023

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Oct 10, 2023

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

Recruiting
  • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
  • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 22, 2023

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Efineptakin alfa
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022